Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?

被引:7
|
作者
Berzenji, Lawek [1 ,2 ]
Wen, Wen [1 ,2 ]
Verleden, Stijn [1 ,2 ]
Claes, Erik [2 ]
Yogeswaran, Suresh Krishan [1 ,2 ]
Lauwers, Patrick [1 ,2 ]
Van Schil, Paul [1 ,2 ]
Hendriks, Jeroen M. H. [1 ,2 ,3 ]
机构
[1] Univ Antwerp, Dept Thorac & Vasc Surg, B-2610 Antwerp, Belgium
[2] Antwerp Surg Training Anat & Res Ctr ASTARC, Lab Thorac & Vasc Surg, B-2650 Edegem, Belgium
[3] Antwerp Univ Hosp, Dept Thorac & Vasc Surg, Drie Eikenstr 655, B-2650 Edegem, Belgium
关键词
minimally invasive surgery; video-assisted thoracoscopic surgery; robotic-assisted thoracoscopic surgery; non-small cell lung cancer; lobectomy; sublobar resections; nodule detection; ASSISTED THORACOSCOPIC SURGERY; THORACIC-SURGERY; LIMITED RESECTION; ROBOTIC LOBECTOMY; RANDOMIZED-TRIAL; OUTCOMES; SEGMENTECTOMY; EXPERIENCE; NODULES; COST;
D O I
10.3390/cancers15174281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards for the majority of procedures performed, especially for early-stage lung cancer. Despite these developments, there is still a lack of concrete data regarding treatment outcomes of these minimally invasive approaches compared to the conventional open surgery. In the future, the number of minimally invasive procedures will likely keep increasing as more lung cancer nodules are detected at early stages due to lung cancer screening initiatives. Therefore, data on short- and long-term outcomes of VATS and RATS in early-stage lung cancer is needed.Abstract In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Updates on Minimally Invasive Surgery in Non-Small Cell Lung Cancer
    Ikeda, Norihiko
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (02)
  • [2] Use of Robotics in Surgical Treatment of Non-small Cell Lung Cancer
    Berzenji, Lawek
    Yogeswaran, Krishan
    Van Schil, Paul
    Lauwers, Patrick
    Hendriks, Jeroen M. H.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (10)
  • [3] Minimally invasive thoracic surgery for early stage non-small cell lung cancer
    Ellis, Peter
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [4] Updates on Minimally Invasive Surgery in Non-Small Cell Lung Cancer
    Norihiko Ikeda
    Current Treatment Options in Oncology, 2019, 20
  • [5] Recent Advancements in Minimally Invasive Surgery for Early Stage Non-Small Cell Lung Cancer: A Narrative Review
    Khan, Jibran Ahmad
    Albalkhi, Ibrahem
    Garatli, Sarah
    Migliore, Marcello
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [6] Targeted therapy in advanced non-small cell lung cancer (NSCLC): Where do we stand?
    Azim, Hatem A., Jr.
    Ganti, Apar Kishor
    CANCER TREATMENT REVIEWS, 2006, 32 (08) : 630 - 636
  • [7] Determinants of successful minimally invasive surgery for resectable non-small cell lung cancer after neoadjuvant therapy
    Ngoc-Quynh Chu
    Tan, Kay See
    Dycoco, Joe
    Adusumilli, Prasad S.
    Bains, Manjit S.
    Bott, Matthew J.
    Downey, Robert J.
    Gray, Katherine D.
    Huang, James
    Isbell, James M.
    Molena, Daniela
    Sihag, Smita
    Rocco, Gaetano
    Jones, David R.
    Park, Bernard J.
    Rusch, Valerie W.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2025, 169 (03) : 753 - +
  • [8] Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go
    Patel, JD
    Pasche, B
    Argiris, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (03) : 175 - 186
  • [9] Thoracoscopic Lobectomy for Non-small Cell Lung Cancer
    Gaudet, Matthew A.
    D'Amico, Thomas A.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 503 - +
  • [10] Oligometastatic non-small cell lung cancer: Where do we go next?
    Malik, Nauman
    Palma, David
    LUNG CANCER, 2017, 106 : 145 - 147